3DΜS Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for 3DΜS with the United States Patent and Trademark Office. The USPTO has given the 3DΜS trademark a serial number of 79401832. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, September 16, 2024. This trademark is owned by Triastek, Inc.. The 3DΜS trademark is filed in the Pharmaceutical Products, Machinery Products, and Computer & Software Services & Scientific Services categories with the following description:

Machines for pharmaceutical processing industry, namely, nozzles and printing heads for drugs and vaccine preparation, industrial robots for conveying of drugs and vaccine preparation, packaging machines for drugs and vaccine preparation; machines for pharmaceutical processing industry, namely, for the preparation of drugs and vaccines; 3D printers; 3D bioprinters.

Veterinary preparations, namely, veterinary vaccines, greases for veterinary purposes, antibiotics for veterinary purposes, bacterial preparations for veterinary purposes, veterinary diagnostic reagents, antibodies for veterinary purposes, anti-infective products for veterinary use; dietetic foods adapted for medical purposes; sugar for medical purposes; dental resin for temporary bridges, crowns and veneers; pharmaceutical preparations for the treatment of bone diseases; biological tissue cultures for medical purposes; fever blister treatment preparations; dysmenorrhea treatment preparations; pharmaceutical preparations for the central nervous system; oral analgesics; anticoagulants; tumor suppressing agents; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for induci...

Scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research services; testing of pharmaceuticals; research and development services of medicines; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; technical research in the field of pharmaceutical studies; quality testing of pharmaceutical product; advisory services relating to material testing.
3dΜs

General Information


Serial Number79401832
Word Mark3DΜS
Filing DateThursday, February 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of standard wording "3DS" with a mathematical symbol between letter "D"and letter "S".
Goods and ServicesMachines for pharmaceutical processing industry, namely, nozzles and printing heads for drugs and vaccine preparation, industrial robots for conveying of drugs and vaccine preparation, packaging machines for drugs and vaccine preparation; machines for pharmaceutical processing industry, namely, for the preparation of drugs and vaccines; 3D printers; 3D bioprinters.
Goods and ServicesVeterinary preparations, namely, veterinary vaccines, greases for veterinary purposes, antibiotics for veterinary purposes, bacterial preparations for veterinary purposes, veterinary diagnostic reagents, antibodies for veterinary purposes, anti-infective products for veterinary use; dietetic foods adapted for medical purposes; sugar for medical purposes; dental resin for temporary bridges, crowns and veneers; pharmaceutical preparations for the treatment of bone diseases; biological tissue cultures for medical purposes; fever blister treatment preparations; dysmenorrhea treatment preparations; pharmaceutical preparations for the central nervous system; oral analgesics; anticoagulants; tumor suppressing agents; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for inducing erections; stimulants for the central nervous system; pharmaceutical preparations for treating allergies; anti-diabetic pharmaceuticals; calcium channel blockers; medicinal preparations for the mouth to be applied in the form of tablets; pharmaceutical preparations for the prevention and treatment of cancer; niacinamide preparations for the treatment of acne; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating hypoglycemia; antihypertensives; chemotherapeutics; antivirals; anti-infectives; chemico-pharmaceutical preparations for the treatment of cancer, oncological diseases, cardiovascular and cerebrovascular diseases, respiratory diseases, genitourinary diseases, neurological diseases, immune system related diseases, gastrointestinal diseases, musculoskeletal diseases and endocrine metabolism-related diseases; living cells for medical use; parathyroid hormone preparations; contraceptive preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; hypnotic sedatives; pharmaceutical products for treating respiratory diseases.
Pseudo Mark3DµS; 3D MU S; 3D MICRO S; THREE DS
Goods and ServicesScientific research for medical purposes in the field of cancerous diseases; pharmaceutical research services; testing of pharmaceuticals; research and development services of medicines; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; technical research in the field of pharmaceutical studies; quality testing of pharmaceutical product; advisory services relating to material testing.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class007 - Machines and machine tools; motors and engines (except for land vehicles); machine coupling and transmission components (except for land vehicles); agricultural implements other than hand-operated; incubators for eggs.
US Class Codes013, 019, 021, 023, 024, 031, 034, 035
Class Status Code6 - Active
Class Status DateThursday, August 15, 2024
Primary Code007
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 15, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTriastek, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Thursday, August 8, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Thursday, August 15, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, August 19, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Monday, August 19, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2024NON-FINAL ACTION WRITTEN
Saturday, September 14, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 16, 2024REFUSAL PROCESSED BY MPU
Tuesday, September 17, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB